Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain-Reference-Cited by-同舟云学术

Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain

Published:2011-06 Issue:6 Volume:19 Page:639-646
ISSN:1063-4584
Container-title:Osteoarthritis and Cartilage
language:en
Short-container-title:Osteoarthritis and Cartilage

Author:

Schnitzer T.J.,Lane N.E.,Birbara C.,Smith M.D.,Simpson S.L.,Brown M.T.

Funder

Pfizer Inc

Publisher

Elsevier BV

Subject

Orthopedics and Sports Medicine,Biomedical Engineering,Rheumatology

Reference26 articles.

1. Prevalence of knee osteoarthritis in the United States: arthritis data from the Third National Health and Nutrition Examination Survey 1991–94;Dillon;J Rheumatol,2006

2. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines;Zhang;Osteoarthritis Cartilage,2008

3. Osteoarthritis: current concepts in diagnosis and management;Manek;Am Fam Physician,2000

4. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT);Jordan;Ann Rheum Dis,2003

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery Systems for Intervertebral Disc;Drug Delivery Systems for Musculoskeletal Tissues;2024

2. The Current Role of Disease-modifying Osteoarthritis Drugs;ARCH BONE JT SURG-AB;2023

3. Biological Therapy for Osteoarthritis, Efficacy and Safety: Focus on Monoclonal Antibodies against Nerve Growth Factor and Fibroblast Growth Factor-18;Open Access Macedonian Journal of Medical Sciences;2022-09-10

4. The challenges of treating osteoarthritis pain and opportunities for novel peripherally directed therapeutic strategies;Neuropharmacology;2022-08

5. Tanezumab for the treatment of osteoarthritis pain;Drugs of Today;2022